Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Chemed To Report Fourth-Quarter 2021 Earnings February 24, Related Conference Call To Be Held On February 25
Chemed To Report Fourth-Quarter 2021 Earnings February 24, Related Conference Call To Be Held On February 25


Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2021, on Thursday, February 24, 2022, following the close of trading

Trex Company Announces Timing of Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
Trex Company Announces Timing of Fourth Quarter and Full Year 2021 Earnings Release and Conference Call


Trex Company, Inc. [NYSE:TREX], the world’s #1 brand of composite decking and railing and leader in high-performance, low-maintenance and eco-friendly outdoor living products and a leading national

onsemi Reports Fourth Quarter and 2021 Financial Results
onsemi Reports Fourth Quarter and 2021 Financial Results


onsemi (the “Company”) (Nasdaq: ON) today announced its fourth quarter and fiscal year 2021 results with the following highlights:




  • Record fiscal year revenue of $6.74 billion representing 28.3%

QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QuantiFERON tuberculosis (TB) testing solution has gained additional momentum with the approval of the fourth

QIAGENs neue Generation des QuantiFERON-TB-Tests erhält Zulassung in China und erneute WHO-Empfehlung
QIAGENs neue Generation des QuantiFERON-TB-Tests erhält Zulassung in China und erneute WHO-Empfehlung


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass seine Tuberkulose (TB)-Testlösung QuantiFERON weiter an Dynamik gewonnen hat, nachdem die vierte Generation des

DGAP-News: HELLA GmbH & Co. KGaA: HELLA and Faurecia set the course for a joint future
DGAP-News: HELLA GmbH & Co. KGaA: HELLA and Faurecia set the course for a joint future
DGAP-News: HELLA GmbH & Co. KGaA: HELLA and Faurecia set the course for a joint future
DGAP-News: HELLA GmbH & Co. KGaA: HELLA und Faurecia stellen Weichen für gemeinsame Zukunft
DGAP-News: HELLA GmbH & Co. KGaA: HELLA und Faurecia stellen Weichen für gemeinsame Zukunft
DGAP-News: HELLA GmbH & Co. KGaA: HELLA und Faurecia stellen Weichen für gemeinsame Zukunft
DGAP-News: Aurubis AG: Aurubis AG steigert operatives Ergebnis im 1. Quartal deutlich und erhöht Gesamtjahresprognose
DGAP-News: Aurubis AG: Aurubis AG steigert operatives Ergebnis im 1. Quartal deutlich und erhöht Gesamtjahresprognose
DGAP-News: Aurubis AG: Aurubis AG steigert operatives Ergebnis im 1. Quartal deutlich und erhöht Gesamtjahresprognose
DGAP-News: Aurubis AG: Aurubis AG considerably boosts operating result in Q1 and increases full-year forecast
DGAP-News: Aurubis AG: Aurubis AG considerably boosts operating result in Q1 and increases full-year forecast
DGAP-News: Aurubis AG: Aurubis AG considerably boosts operating result in Q1 and increases full-year forecast
Washington Federal Bank Announces Completion of Conversion to Washington State Chartered Commercial Bank
Washington Federal Bank Announces Completion of Conversion to Washington State Chartered Commercial Bank


Washington Federal Bank, the wholly owned subsidiary of Washington Federal, Inc. (Nasdaq: WAFD) (the "Company"), today announced the successful completion of its conversion from a national bank

Kohl’s Board of Directors Provides Update on Review of Unsolicited Expressions of Interest
Kohl’s Board of Directors Provides Update on Review of Unsolicited Expressions of Interest


Kohl’s Corporation (NYSE:KSS) (“Kohl’s” or the “Company”) today issued the following statement:



The Kohl's Board of Directors (the Board) has determined, following a review with its independent

DGAP-News: HELLA GmbH & Co. KGaA: Einvernehmliche Amtsbeendigung mit Vorsitzendem der Geschäftsführung Dr. Rolf Breidenbach
DGAP-News: HELLA GmbH & Co. KGaA: Einvernehmliche Amtsbeendigung mit Vorsitzendem der Geschäftsführung Dr. Rolf Breidenbach
DGAP-News: HELLA GmbH & Co. KGaA: Einvernehmliche Amtsbeendigung mit Vorsitzendem der Geschäftsführung Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Termination of office by mutual agreement with Chairman of the Management Board Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Termination of office by mutual agreement with Chairman of the Management Board Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Termination of office by mutual agreement with Chairman of the Management Board Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Einvernehmliche Amtsbeendigung mit Vorsitzendem der Geschäftsführung Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Einvernehmliche Amtsbeendigung mit Vorsitzendem der Geschäftsführung Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Einvernehmliche Amtsbeendigung mit Vorsitzendem der Geschäftsführung Dr. Rolf Breidenbach
DGAP-Adhoc: Evotec SE: Bayer stellt den klinischen Entwicklungskandidaten Eliapixant (BAY1817080) ein; Evotec erhält Rechte für alle P2X3-Assets zurück
DGAP-Adhoc: Evotec SE: Bayer stellt den klinischen Entwicklungskandidaten Eliapixant (BAY1817080) ein; Evotec erhält Rechte für alle P2X3-Assets zurück
DGAP-Adhoc: Evotec SE: Bayer stellt den klinischen Entwicklungskandidaten Eliapixant (BAY1817080) ein; Evotec erhält Rechte für alle P2X3-Assets zurück
DGAP-Adhoc: Evotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assets
DGAP-Adhoc: Evotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assets
DGAP-Adhoc: Evotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assets
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA and free cash flow for full year 2021 significantly exceed previous outlook
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA and free cash flow for full year 2021 significantly exceed previous outlook
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA and free cash flow for full year 2021 significantly exceed previous outlook
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA und Freier Cashflow übertreffen im Gesamtjahr 2021 deutlich bisherige Prognose
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA und Freier Cashflow übertreffen im Gesamtjahr 2021 deutlich bisherige Prognose
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA und Freier Cashflow übertreffen im Gesamtjahr 2021 deutlich bisherige Prognose
American States Water Company Announces Regular Common Dividends
American States Water Company Announces Regular Common Dividends


On February 1, 2022, the Board of Directors of American States Water Company (NYSE:AWR) approved a quarterly dividend of $0.365 per share on the Common Shares of the company. This action marks the

Power Integrations Reports Fourth-Quarter and Full-Year Financial Results
Power Integrations Reports Fourth-Quarter and Full-Year Financial Results


Power Integrations (Nasdaq: POWI) today announced financial results for the quarter and year ended December 31, 2021. Net revenues for the fourth quarter of 2021 were $172.7 million, down two

SREP capital requirements for Commerzbank to remain unchanged for 2022
SREP capital requirements for Commerzbank to remain unchanged for 2022
SREP capital requirements for Commerzbank to remain unchanged for 2022
DGAP-Adhoc: SREP-Kapitalanforderungen der Commerzbank für 2022 unverändert
DGAP-Adhoc: SREP-Kapitalanforderungen der Commerzbank für 2022 unverändert
DGAP-Adhoc: SREP-Kapitalanforderungen der Commerzbank für 2022 unverändert
DGAP-Adhoc: SREP capital requirements for Commerzbank to remain unchanged for 2022
DGAP-Adhoc: SREP capital requirements for Commerzbank to remain unchanged for 2022
DGAP-Adhoc: SREP capital requirements for Commerzbank to remain unchanged for 2022
Cushman & Wakefield Arranges $132M Sale of Multifamily Community in Georgia
Cushman & Wakefield Arranges $132M Sale of Multifamily Community in Georgia


Cushman & Wakefield (NYSE: CWK) announced that the commercial real estate services firm has arranged the sale of Park at Abernathy Square, a 484-unit apartment community located in Sandy Springs

DGAP-Adhoc: Talanx Aktiengesellschaft: Talanx significantly exceeds profit forecast for FY 2021 with preliminary Group net income of EUR 1.01 billion
DGAP-Adhoc: Talanx Aktiengesellschaft: Talanx significantly exceeds profit forecast for FY 2021 with preliminary Group net income of EUR 1.01 billion
DGAP-Adhoc: Talanx Aktiengesellschaft: Talanx significantly exceeds profit forecast for FY 2021 with preliminary Group net income of EUR 1.01 billion